New drug alternatives
A TIENTS who do not respond to AZT -the primary AIDS therapeutic drug produced and patented almo worldwide by Burroughs Wellcome Co -now have hope.
Studies at the US Nationi Institutes of Health at Bethesd Maryland, show two other drugs . le DDC produced by Hoffmann at Roche Inc and DDI, by Bristol-Meye Squibb Co -are "similarly effectively in slowing the progress of AIDS patients not responding to AZT .
DDI is already officially approved for use by people whose condition is worsens on taking AZT, but only as a supporting drug along with AZT. re Researchers, however, caution DDC be can result in painful nerve damage to arms and legs and Dm can cause stomach upsets and pancreatitis.
Related Content
- Order of the High Court of Kerala regarding pricing of breast cancer medicines, 02/11/2023
- Antimicrobial movement from agricultural areas to the environment: the missing link- a role for nuclear techniques
- Curd-peptide based novel hydrogel inhibits biofilm formation, quorum sensing, swimming mortility of multi-antibiotic resistant clinical isolates and accelerates wound healing activity
- Go back to ancient ways to stop cancer
- Kenya plans new regulatory framework for alternative medicine
- Alternative therapeutics for self-limiting infections—An indirect approach to the antibiotic resistance challenge